- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
It is well-known in the medical field that antibodies to hepatitis B surface antigen (HBsAg), anti-HBs, are capable of neutralizing HBsAg and clearance of HBV, which is characterized by the emergence of anti-HBs and the disappearance of HBsAg from peripheral blood4. Hence it is a conundrum when both HBsAg and anti-HBs are present in same serological profile5. However, incidences of coexisting of HBsAg and anti-HBs among HBsAg positive patients has been increasingly reported, which is nearly 5% in China5, 21% in Japan6, 36% in Netherlands7, 2.8% in France8, 2.9% in South Korea9, varies from 2.8% to 36%5,6,7,8,9,10 and progressively increases with patient age from 40 to 70 years old11.
The molecular mechanism underlying the emergence of coexisting HBsAg and anti-HBs remains unclear. Several studies have been attributed to the selection of immune escape mutations in HBV genome, especially the determinant region (amino acids 124–147) of HBsAg, from one or a few viral strains4, 8, 12,13,14. Viral replication and the host immune response are two vital processes that interplay during HBV infection. The compact HBV genome contains four overlapping regions: preS/S completely overlaps with polymerase region, and HBxAg and HBcAg each partly overlap with polymerase region15, 16. These regions encode 7 proteins: DNA polymerase (Pol), three envelope proteins (LHBsAg, MHBsAg and HBsAg), core protein (HBcAg), X protein (HBx), and e protein (HBeAg). LHBsAg, MHBsAg, and HBsAg are structural proteins, while HBx regulates viral DNA replication and interferes with the host cell17. There are three types of Pol acting on DNA replication, and HBeAg may contribute to T cell immunological tolerance18.
Owing to a high replication rate and a lack of proof-reading capacity during reverse transcription, HBV exist as quasispecies19. Quasispecies is a population of closely related, but genetically distinct variants capable surviving living in a mutagenic environment19. The spectrum of mutants possess differing levels of fitness in a range of environments20. Thus, the serological profiles of HBV patients may be affected by competition among viral variants within quasispecies (differences in replicative efficiency)19 and/or host immune reactivity21. |
|